Healios K.K. (HLOSF)
USD 1.35
(0.0%)
USD 1.35
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 121 Million JPY | 17534.37% |
| 2022 | 686.16 Thousand JPY | 92.67% |
| 2021 | 356.12 Thousand JPY | 36.18% |
| 2020 | 261.51 Thousand JPY | -68.07% |
| 2019 | 818.95 Thousand JPY | 0.0% |
| 2018 | - JPY | -100.0% |
| 2017 | 27.66 Million JPY | -64.37% |
| 2016 | 77.64 Million JPY | 9414.1% |
| 2015 | 816.05 Thousand JPY | -99.71% |
| 2014 | 279.99 Million JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 498 Million JPY | 4880.0% |
| 2024 Q1 | 66.07 Thousand JPY | 42.86% |
| 2023 Q2 | 692.8 Thousand USD | 1214.89% |
| 2023 FY | 121 Million JPY | 17534.37% |
| 2023 Q4 | 49.6 Thousand USD | 5.9% |
| 2023 Q1 | 52.68 Thousand USD | -88.48% |
| 2023 Q3 | 46.84 Thousand USD | -93.24% |
| 2022 Q2 | 81 Thousand JPY | -99.26% |
| 2022 Q4 | 457.44 Thousand JPY | 727.86% |
| 2022 Q3 | 55.25 Thousand JPY | -31.79% |
| 2022 Q1 | 11 Million JPY | 0.0% |
| 2022 FY | 686.16 Thousand JPY | 92.67% |
| 2021 FY | 356.12 Thousand JPY | 36.18% |
| 2021 Q2 | 90.09 Thousand JPY | 10.62% |
| 2021 Q4 | 11 Million JPY | 0.0% |
| 2021 Q1 | 81.44 Thousand JPY | -98.64% |
| 2021 Q3 | 11 Million JPY | 12108.93% |
| 2020 Q1 | 7 Million JPY | 0.0% |
| 2020 FY | 261.51 Thousand JPY | -68.07% |
| 2020 Q3 | 7 Million JPY | 0.0% |
| 2020 Q2 | 7 Million JPY | 0.0% |
| 2020 Q4 | 6 Million JPY | -14.29% |
| 2019 Q4 | - JPY | -100.0% |
| 2019 Q3 | 7 Million JPY | 120.59% |
| 2019 Q1 | 109 Million JPY | 0.0% |
| 2019 Q2 | -34 Million JPY | -131.19% |
| 2019 FY | 818.95 Thousand JPY | 0.0% |
| 2018 Q1 | - JPY | 0.0% |
| 2018 Q3 | - JPY | 0.0% |
| 2018 Q2 | - JPY | 0.0% |
| 2018 FY | - JPY | -100.0% |
| 2018 Q4 | - JPY | 0.0% |
| 2017 Q1 | 20 Million JPY | 0.37% |
| 2017 FY | 27.66 Million JPY | -64.37% |
| 2017 Q2 | 6.7 Million JPY | -66.5% |
| 2017 Q4 | - JPY | 0.0% |
| 2017 Q3 | - JPY | -100.0% |
| 2016 Q2 | 21.2 Million JPY | 2.61% |
| 2016 FY | 77.64 Million JPY | 9414.1% |
| 2016 Q4 | 19.92 Million JPY | 25.73% |
| 2016 Q3 | 15.84 Million JPY | -25.26% |
| 2016 Q1 | 20.66 Million JPY | -5.36% |
| 2015 Q2 | 39.24 Million JPY | 97.38% |
| 2015 Q4 | 21.83 Million JPY | 26.91% |
| 2015 Q3 | 17.2 Million JPY | -56.16% |
| 2015 Q1 | 19.88 Million JPY | 0.0% |
| 2015 FY | 816.05 Thousand JPY | -99.71% |
| 2014 FY | 279.99 Million JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 15.77 Million USD | -667.134% |
| Nanobac Pharmaceuticals, Incorporated | 17.62 Thousand USD | -686580.665% |
| SQZ Biotechnologies Company | 21.47 Million USD | -463.367% |
| Evofem Biosciences, Inc. | 18.21 Million USD | -564.178% |
| Santhera Pharmaceuticals Holding AG | 122.95 Million USD | 1.589% |
| Mesoblast Limited | 5.9 Million USD | -1950.152% |
| Propanc Biopharma, Inc. | - USD | -Infinity% |
| Genus plc | 668.8 Million USD | 81.908% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -29400.323% |
| Marizyme, Inc. | 645.81 Thousand USD | -18636.161% |
| ContraFect Corporation | - USD | -Infinity% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| PsyBio Therapeutics Corp. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -157532.131% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -183992.016% |
| AXIM Biotechnologies, Inc. | 39.51 Thousand USD | -306089.584% |
| MultiCell Technologies, Inc. | 49.32 USD | -245336477.453% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 49.72 Million USD | -143.358% |
| EV Biologics, Inc. | 48.9 Thousand USD | -247343.763% |
| Q BioMed Inc. | 284.35 Thousand USD | -42452.892% |
| Emmaus Life Sciences, Inc. | 29.59 Million USD | -308.825% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | - USD | -Infinity% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 245.31 Million USD | 50.676% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -172757.143% |
| Skye Bioscience, Inc. | - USD | -Infinity% |
| Therapeutic Solutions International, Inc. | 98.99 Thousand USD | -122129.63% |
| THC Farmaceuticals, Inc. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | 75.72 Thousand USD | -159690.819% |
| IMV Inc. | - USD | -Infinity% |
| Acro Biomedical Co., Ltd. | 658.5 Thousand USD | -18275.095% |
| Curative Biotechnology, Inc. | - USD | -Infinity% |
| GB Sciences, Inc. | - USD | -Infinity% |
| Alpha Cognition Inc. | - USD | -Infinity% |
| HST Global, Inc. | - USD | -Infinity% |
| CSL Limited | 14.69 Billion USD | 99.176% |
| Halberd Corporation | 999.00 USD | -12112012.112% |
| Enzolytics Inc. | 52.79 Thousand USD | -229084.029% |
| Resverlogix Corp. | - USD | -Infinity% |
| Affymax, Inc. | 1.36 Million USD | -8738.568% |
| SYBLEU INC | 11.69 Thousand USD | -1034441.724% |
| Nuo Therapeutics, Inc. | 608.52 Thousand USD | -19784.146% |
| argenx SE | 1.22 Billion USD | 90.133% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 1.93 Million USD | -6162.94% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -19498.823% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Genscript Biotech Corporation | 839.52 Million USD | 85.587% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | - USD | -Infinity% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| American Oriental Bioengineering, Inc. | 145.09 Million USD | 16.609% |
| Provectus Biopharmaceuticals, Inc. | 557.71 Thousand USD | -21595.863% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 997.72 Thousand USD | -12027.578% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 48.35 Million USD | -150.238% |
| Cotinga Pharmaceuticals Inc. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 16.68 Million USD | -625.185% |
| ONE Bio Corp. | 52.29 Million USD | -131.374% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Agentix Corp. | - USD | -Infinity% |
| LadRx Corporation | - USD | -Infinity% |
| Cell Source, Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 236.56 Thousand USD | -51049.814% |
| Regen BioPharma, Inc. | 236.56 Thousand USD | -51049.814% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | 140.24 Thousand USD | -86179.431% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| CytoDyn Inc. | - USD | -Infinity% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 473.73 Thousand USD | -25441.975% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | - USD | -Infinity% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| International Stem Cell Corporation | 7.78 Million USD | -1453.473% |
| Bioxytran, Inc. | - USD | -Infinity% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 13 Thousand USD | -930669.231% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | - USD | -Infinity% |
| Neutra Corp. | 39.53 Thousand USD | -305965.665% |
| Windtree Therapeutics, Inc. | - USD | -Infinity% |
| PureTech Health plc | 3.33 Million USD | -3533.634% |
| Coeptis Therapeutics, Inc. | - USD | -Infinity% |
| IXICO plc | 6.66 Million USD | -1715.454% |
| IntelGenx Technologies Corp. | 1.03 Million USD | -11545.813% |
| Gelesis Holdings, Inc. | 25.76 Million USD | -369.593% |
| CSL Limited | 14.8 Billion USD | 99.182% |
| Cellectis S.A. | 755 Thousand USD | -15926.49% |